Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2002
10/31/2002CA2444959A1 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444599A1 Melanocortin receptor ligands
10/31/2002CA2444370A1 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2444219A1 Antiangiogenic combination therapy for the treatment of cancer
10/31/2002CA2443946A1 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
10/31/2002CA2443936A1 Use of ppar-alpha-gamma ligands or agonists to prevent the rupture of atherosclerotic plaques
10/31/2002CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002CA2443587A1 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002CA2429351A1 A novel human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/30/2002EP1252895A1 Remedies for ophthalmic diseases
10/30/2002EP1252894A1 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions
10/30/2002EP1252313A2 Use of dendroaspin as a vehicle for non-dendroaspin domains
10/30/2002EP1252310A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof
10/30/2002EP1252306A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr
10/30/2002EP1252300A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
10/30/2002EP1252298A2 Phosphodiesterases
10/30/2002EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels
10/30/2002EP1252188A2 G-protein coupled receptors
10/30/2002EP1252177A1 Ligand for vascular endothelial growth factor receptor
10/30/2002EP1252165A1 Isoxazolo pyrimidinones and the use thereof
10/30/2002EP1252161A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor
10/30/2002EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002EP1252154A1 Heterocyclic amide derivatives
10/30/2002EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002EP1252144A1 Substituted glutarimides and use thereof il-12 production inhibitors
10/30/2002EP1252143A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives
10/30/2002EP1252137A1 Palatable arginine compounds and uses thereof for cardiovascular health
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1251864A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
10/30/2002EP1251862A1 Ophthalmic compositions for treating ocular hypertension
10/30/2002EP1251855A1 Selective estrogen receptor modulators in combination with estrogens
10/30/2002EP1251851A1 Treating allergic and inflammatory conditions
10/30/2002EP1251843A1 Compositions for delivery of a cortisol antagonist
10/30/2002EP1251837A2 Compounds and methods for modulating cerebral amyloid angiopathy
10/30/2002EP1251831A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor
10/30/2002EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002EP1090017B1 Novel compounds derived from alpha-d-xylose, preparation method and therapeutic use
10/30/2002EP1005449B1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same
10/30/2002EP0854863B1 Esters and amides as pla2 inhibitors
10/30/2002EP0852225B1 Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
10/30/2002EP0775126B1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
10/30/2002EP0689449B1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine
10/30/2002CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer
10/30/2002CN1377408A The PRV-1 gene and use thereof
10/30/2002CN1377368A 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
10/30/2002CN1377366A 5-hydroxysapogenin derivatives with anti-dementia activity
10/30/2002CN1377365A Eplerenone crystalline form exhibiting enhanced dissolution rate
10/30/2002CN1377357A Pyrazolo [4,3-d] pyrimidines
10/30/2002CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002CN1377355A Amino substituted pyrazolo [1,5-2]-1,5-pyrimidines and pyrazolo [1,5-2]-1,3, 5-triazines
10/30/2002CN1377354A Certain alkylene diamine-substituted pyrazolo [1,5-a]-1,5-pyrimidines and pyrazolo [1,5-a]-1,3,5-triazines
10/30/2002CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002CN1377349A Quiunclidine compounds and drugs containing the same as the active ingredient
10/30/2002CN1377348A 4,5-diaryloxazole compounds with prostaglandin 12 (PG12) agonistic activity
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002CN1377346A Z-pyrazoline-5-ones
10/30/2002CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002CN1377277A Use of leptin in inhibition of endothelial cell proliferation
10/30/2002CN1377271A Use of thienopyrimidines
10/30/2002CN1377269A Vitronectin receptor antagonists
10/30/2002CN1377266A Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
10/30/2002CN1377263A Neuropathy improves containing nitrogenous compounds as the active ingredient
10/30/2002CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002CN1376675A Arginine-aescin with functions of detumescence, relieving inflammation and improving blood circulation and its preapring process
10/30/2002CN1376506A Medicine for treating hemiplegia sequela and its preparing process
10/30/2002CN1376504A Intravenous injection of Chinese angelica root and its preparing process
10/30/2002CN1376491A Medicine for treating myocardial infarction and angina pectoris
10/30/2002CN1093536C 5-lipoxygenase inhibitor
10/30/2002CN1093423C Novel brain endotheliai cell protein and methods for its use
10/30/2002CN1093416C Plant Medicine for treating cardiovascular medicine and its preparing process
10/30/2002CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002US6472563 Recrystallization from aqueous isopropyl alcohol; high purity; thermodynamically stable
10/29/2002US6472562 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
10/29/2002US6472530 Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods
10/29/2002US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates
10/29/2002US6472436 Blocking amyloid protein toxicity in cells using polycylic compounds. also provided are novel methods of decreasing amyloid protein production in cells and methods of inhibiting cell death. invention methods can be used to prevent and treat
10/29/2002US6472434 Vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. suitable vasoactive agents are vasodilators, including naturally occurring prostaglandins, synthetic prostaglandin derivatives,
10/29/2002US6472421 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
10/29/2002US6472413 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
10/29/2002US6472405 Glycoprotein IIB/IIIA antagonists
10/29/2002US6472401 Administering an antiallergen of loratadine or metabolite of loratadine, desloratadine; migraines, stroke, orthostatic hypotension, gastrointestinal stasis, nausea, dizziness and jet lag; also psychological disorders; 5-ht7 receptors
10/29/2002US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002US6472399 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/29/2002US6472393 Serine protease inhibitors
10/29/2002US6472390 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
10/29/2002US6472386 Cyclic diamine compound with 5-membered ring groups
10/29/2002US6472382 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
10/29/2002US6472379 Angiogenesis inhibition
10/29/2002US6472378 Compositions and methods for treatment of mitochondrial diseases
10/29/2002US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002US6472165 Modulatory binding site in potassium channels for screening and finding new active ingredients
10/29/2002US6471997 Antagonist of calcitonin gene related peptide, cgrp and/or of substance p; cosmetic
10/29/2002US6471979 Applying formulation comprising a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (serm) to stent; inserting stent for releasing formulation
10/29/2002US6471968 Multifunctional nanodevice platform
10/29/2002CA2236553C Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
10/29/2002CA2068231C Process for the preparation of benzothiazepines by cyclization with phosphonic acids
1 ... 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 ... 1595